首页> 外文期刊>Annals of xcience and technology policy >F Case Study of HHS National Institutes of Health Technology Transfer: Human Papillomavirus Vaccine
【24h】

F Case Study of HHS National Institutes of Health Technology Transfer: Human Papillomavirus Vaccine

机译:美国卫生和公众服务部(National Institutes of Health)的案例研究技术转让:人类乳头状瘤病毒疫苗

获取原文
获取原文并翻译 | 示例
           

摘要

Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, infecting 42% of people aged 15 to 59 in 2008 (Satterwhite et al., 2013). Although most infections cause no symptoms and go away on their own within a few years, some last longer and can progress to genital warts or cancer, depending on the HPV type. HPV causes an estimated 610,000 cancers each year worldwide, 80% of these in less developed countries.
机译:人类乳头瘤病毒(HPV)是最常见的性传播感染的感染,42%的人在15至59岁2008 (Satterwhite et al ., 2013)。感染引起任何症状和消失自己的几年之内,一些持续时间更长,可以生殖器疣或癌症进展,根据人乳头状瘤病毒类型。癌症每年在全球范围内,80%的这些更少发达国家。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号